CASE STUDY TOP 20 GLOBAL PHARMA COMPANY MAKES COST SAVINGS OF ALMOST $5M Top 20 global pharma company makes cost savings of almost $5million per year in Phase III study from utilising Almac’s Supply Chain Management expertise mid-trial.BACKGROUND Our client, one of the top 20 global, pharmaceutical companies was conducting a phase III trial to compare the efficacy, safety, and tolerability of multiple doses of Investigational Medic

Join for free to read